Suparma Tbk Stock Price To Sales
| SPMA Stock | IDR 302.00 2.00 0.67% |
Suparma Tbk fundamentals help investors to digest information that contributes to Suparma Tbk's financial success or failures. It also enables traders to predict the movement of Suparma Stock. The fundamental analysis module provides a way to measure Suparma Tbk's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Suparma Tbk stock.
Suparma |
Suparma Tbk Company Price To Sales Analysis
Suparma Tbk's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Suparma Tbk Price To Sales | 0.50 X |
Most of Suparma Tbk's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Suparma Tbk is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Suparma Tbk has a Price To Sales of 0.5033 times. This is 98.1% lower than that of the Paper & Forest Products sector and 11.7% lower than that of the Materials industry. The price to sales for all Indonesia stocks is 95.59% higher than that of the company.
Suparma Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Suparma Tbk's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Suparma Tbk could also be used in its relative valuation, which is a method of valuing Suparma Tbk by comparing valuation metrics of similar companies.Suparma Tbk is currently under evaluation in price to sales category among its peers.
Suparma Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 1.45 T | |||
| Shares Outstanding | 3.15 B | |||
| Shares Owned By Insiders | 92.37 % | |||
| Price To Earning | 3.91 X | |||
| Price To Sales | 0.50 X | |||
| Revenue | 2.79 T | |||
| Gross Profit | 582.39 B | |||
| EBITDA | 619.88 B | |||
| Net Income | 294.33 B | |||
| Cash And Equivalents | 137.63 B | |||
| Cash Per Share | 49.31 X | |||
| Total Debt | 308.5 B | |||
| Debt To Equity | 0.37 % | |||
| Current Ratio | 1.47 X | |||
| Book Value Per Share | 653.74 X | |||
| Cash Flow From Operations | 791.81 B | |||
| Earnings Per Share | 128.42 X | |||
| Number Of Employees | 758 | |||
| Beta | 0.6 | |||
| Market Capitalization | 1.59 T | |||
| Total Asset | 2.75 T | |||
| Z Score | 4.0 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 2.75 T |
About Suparma Tbk Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Suparma Tbk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Suparma Tbk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Suparma Tbk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Suparma Stock
Suparma Tbk financial ratios help investors to determine whether Suparma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suparma with respect to the benefits of owning Suparma Tbk security.